CLINICAL_TRIALS
trial_result
· 2017-06-26
Clinical Trial Update: Colesevelam as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus [Phase 3]
Summary
Phase 3 trial evaluating Colesevelam added to pioglitazone therapy in Type 2 Diabetes Mellitus has completed. Results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Daiichi Sankyo | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2017-06-26